Marketplace Materials
Case Study: Phase II MS Trial
A large, global sponsor was facing increasing internal competition and needed a way to confidently expand their site network.
This sponsor was also looking to broaden their geographic reach and access diverse patients. Find out how partnering with community-based sites through Inato's Marketplace accomplished all of these goals and more.
Case Study: Phase III AAD Trial
A large, global sponsor was experiencing difficulties in hitting enrollment numbers for an Agitation in Alzheimer's Dementia trial. Having closed many sites due to slow enrollment, the study team needed help in identifying experienced sites with access to their target patient population.
The sponsor collaborated with Inato to access untapped patient populations and identify qualified sites that could enroll patients in just two months. Discover how partnering with Inato allowed them to meet their trial goals and accelerate their timeline.
Case Study: Phase III MDD Trial
A large global sponsor was facing an increasingly tight timeline for a U.S. based Major Depressive Disorder trial due slow enrollment and complications with the digital requirements of the study. They were looking for solutions to accelerating their timelines as well as increasing their collaborative role in the recruitment and selection process.
The sponsor collaborated with Inato to develop a way to combat their limited time frame. Learn how partnering with Inato allowed them to achieve their goals across activation and enrollment.
Case Study: Portfolio Collaboration
A global sponsor was facing challenges in their trials brought on by the COVID-19 pandemic. With an increase of competition at large research sites and a decrease in patients visiting their physicians they sought out an alternative solution to eliminate trial obstacles.
The sponsor's collaboration with Inato broadened their access to diverse patient populations and boosted the efficiency of their studies. Find out how Inato's network of community-based sites allowed this sponsor overcome trial delays and hit their targets.
Inato's Inclusive Research Program
In recent history, we've made some incredible medical innovations through trials. But not everyone has access. Let's change that.
Throughout the world, if you fall within a minority or otherwise marginalized group, it's not only more likely that you won't have access to clinical trial research but also that a breakthrough drug hasn't been adequately tested on people of your ethnicity or background. Sponsors want their trials to be inclusive because it leads to more robust analysis, faster drug approvals, and improved patient outcomes. However, it's not always easy to engage underserved patients in research.
That's where community sites come in. By partnering with investigators who already have trusted relationships with patients and deep ties to the community, sponsors can reach untapped patient populations.
**Inato's Inclusive Research Program connects sponsors with proven-diverse sites, making sure the latest medical innovations are safe and effective for everyone.**
